دورية أكاديمية

Cost-Effectiveness Analysis of Trastuzumab Deruxtecan Versus Trastuzumab Emtansine for Patients With Human Epidermal Growth Factor Receptor 2 Positive Metastatic Breast Cancer in the United States

التفاصيل البيبلوغرافية
العنوان: Cost-Effectiveness Analysis of Trastuzumab Deruxtecan Versus Trastuzumab Emtansine for Patients With Human Epidermal Growth Factor Receptor 2 Positive Metastatic Breast Cancer in the United States
المؤلفون: Mudumba, Rahul, Chan, Hui-Hsuan, Cheng, Yuan-Yuan, Wang, Chien-Chen, Correia, Luis, Ballreich, Jeromie, Levy, Joseph
المصدر: In Value in Health February 2024 27(2):153-163
قاعدة البيانات: ScienceDirect
الوصف
تدمد:10983015
DOI:10.1016/j.jval.2023.11.004